KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
16.06
-0.22 (-1.35%)
Mar 2, 2026, 4:00 PM EST - Market closed
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $811.77 million as of March 3, 2026. Its market cap has increased by 76.05% in one year.
Market Cap
811.77M
Enterprise Value
758.77M
1-Year Change
76.05%
Ranking
Category
Stock Price
$16.06
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $811.77M, an increase of 527.82%. That is a compound annual growth rate of 18.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 822.90M | 0.81% |
| Dec 31, 2025 | 816.30M | 95.01% |
| Dec 31, 2024 | 418.60M | -1.11% |
| Dec 29, 2023 | 423.30M | 154.39% |
| Dec 30, 2022 | 166.40M | -48.59% |
| Dec 31, 2021 | 323.70M | -4.99% |
| Dec 31, 2020 | 340.70M | 7.27% |
| Dec 31, 2019 | 317.60M | -6.64% |
| Dec 31, 2018 | 340.20M | 223.69% |
| Dec 29, 2017 | 105.10M | 690.23% |
| Dec 30, 2016 | 13.30M | -86.04% |
| Dec 31, 2015 | 95.30M | -26.30% |
| Apr 9, 2015 | 129.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omeros | 854.35M |
| Arvinas | 848.76M |
| SELLAS Life Sciences Group | 839.49M |
| Annexon | 834.71M |
| Janux Therapeutics | 827.92M |
| Evommune | 819.63M |
| Prime Medicine | 817.92M |
| BridgeBio Oncology Therapeutics | 802.29M |